Clinical Trial Update: Long-term Sedation With Remimazolam Besylate in Critically Ill Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating long-term sedation with remimazolam besylate in critically ill patients requiring light sedation and mechanical vent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Light Sedation Requirement in Mechanically Ventilated Patients

Drugs mentioned

• Remimazolam besylate (remimazolam besylate)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Light Sedation, Mechanical Ventilation | Phase 3 | Status: UNKNOWN